Literature DB >> 21035355

The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma.

Ruihong Zeng1, Caixia Li, Na Li, Lin Wei, YuXiu Cui.   

Abstract

Respiratory syncytial virus (RSV) is the primary cause of serious lower respiratory tract illness in infants and young children worldwide. The mechanism is largely unknown. RSV stimulates airway epithelial cells and resident leukocytes to release cytokines. Cytokines and chemokines involved in host response to RSV infection are thought to play a central role in the pathogenesis. In addition, RSV infection early in life has been associated with the development of asthma in later childhood. It is likely that the persistence of cytokines and chemokines in fully recovered patients with RSV in the long term can provide a substratum for the development of subsequent asthma. This review describes the genetic factors in cytokines and chemokines associated with severity of RSV disease, cytokines and chemokines synthesis in RSV infection, and the role of these innate immune components in RSV-associated asthma.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035355     DOI: 10.1016/j.cyto.2010.09.011

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

Review 1.  Infection-related asthma.

Authors:  Jared I Darveaux; Robert F Lemanske
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-06

2.  Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection.

Authors:  Birthe Jessen; Simone Faller; Christine D Krempl; Stephan Ehl
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

3.  Oxysophocarpine inhibits lung injury induced by respiratory syncytial virus.

Authors:  Jie Gao; Ying Li; Qiwei Wang; Xiaojian Ma; Yan Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

4.  Inhibition of respiratory syncytial virus replication and suppression of RSV-induced airway inflammation in neonatal rats by colchicine.

Authors:  Nihong Lu; Yongrui Yang; Honglu Liu; Xiangli Ding; Yangbing Ou; Jiawei Xia; Yingrong Du
Journal:  3 Biotech       Date:  2019-10-10       Impact factor: 2.406

5.  Cytokines in chronic respiratory diseases.

Authors:  Sergei P Atamas; Svetlana P Chapoval; Achsah D Keegan
Journal:  F1000 Biol Rep       Date:  2013-02-01

6.  Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs.

Authors:  Fatoumata B Sow; Jack M Gallup; Subramaniam Krishnan; Andriani C Patera; Joann Suzich; Mark R Ackermann
Journal:  Respir Res       Date:  2011-08-09

7.  IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice.

Authors:  Jens Loebbermann; Corinna Schnoeller; Hannah Thornton; Lydia Durant; Nathan P Sweeney; Martijn Schuijs; Anne O'Garra; Cecilia Johansson; Peter J Openshaw
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6.

Authors:  Xuelian Yu; Xi Zhang; Baihui Zhao; Jiayu Wang; Zhaokui Zhu; Zheng Teng; Junjie Shao; Jiaren Shen; Ye Gao; Zhengan Yuan; Fan Wu
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

9.  Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus.

Authors:  Baocheng Deng; Shujun Zhang; Yingzhi Geng; Yuzhong Zhang; Yuncheng Wang; Wenqing Yao; Ying Wen; Wei Cui; Ying Zhou; Qiuhong Gu; Wen Wang; Yu Wang; Zhen Shao; Yanli Wang; Chengbo Li; Donglei Wang; Yitong Zhao; Pei Liu
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

10.  Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine.

Authors:  Manuel Mata; Irene Sarrion; Miguel Armengot; Carmen Carda; Isidoro Martinez; Jose A Melero; Julio Cortijo
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.